Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Pulmonx Corp (NASDAQ: LUNG) closed at $3.77 down -21.95% from its previous closing price of $4.83. In other words, the price has decreased by -$21.95 from its previous closing price. On the day, 1.55 million shares were traded. LUNG stock price reached its highest trading level at $5.459 during the session, while it also had its lowest trading level at $3.605.
Ratios:
For a deeper understanding of Pulmonx Corp’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.88 and its Current Ratio is at 5.58. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.61.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, D. Boral Capital on March 10, 2025, initiated with a Buy rating and assigned the stock a target price of $17.
On December 11, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $17 to $7.50.
On June 04, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.Lake Street initiated its Buy rating on June 04, 2024, with a $12 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 20 ’25 when French Glendon E. III sold 20,000 shares for $7.85 per share. The transaction valued at 157,000 led to the insider holds 991,974 shares of the business.
GLENDON FRENCH bought 60,000 shares of LUNG for $466,200 on Mar 20 ’25. On Mar 03 ’25, another insider, Joshi Mehul, who serves as the Chief Financial Officer & PAO of the company, sold 14,384 shares for $7.12 each. As a result, the insider received 102,414 and left with 113,986 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LUNG now has a Market Capitalization of 151733072 and an Enterprise Value of 118876064. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.81 while its Price-to-Book (P/B) ratio in mrq is 1.75. Its current Enterprise Value per Revenue stands at 1.359 whereas that against EBITDA is -2.178.
Stock Price History:
The Beta on a monthly basis for LUNG is 0.65, which has changed by -0.6160896 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, LUNG has reached a high of $10.01, while it has fallen to a 52-week low of $4.15. The 50-Day Moving Average of the stock is -44.13%, while the 200-Day Moving Average is calculated to be -44.60%.
Shares Statistics:
For the past three months, LUNG has traded an average of 363.92K shares per day and 414860 over the past ten days. A total of 39.79M shares are outstanding, with a floating share count of 34.62M. Insiders hold about 13.98% of the company’s shares, while institutions hold 85.62% stake in the company. Shares short for LUNG as of 1744675200 were 1171610 with a Short Ratio of 3.22, compared to 1741910400 on 1166359. Therefore, it implies a Short% of Shares Outstanding of 1171610 and a Short% of Float of 4.29.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
